Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

{
  "signal_id": "29c6687b-2b42-c56d-4cdb-d91e69b9d664",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-07-23T13:02:38+00:00",
  "company": {
    "name": "Quest Diagnostics",
    "domain": "questdiagnostics.com"
  },
  "data": {
    "url": "https://www.biospace.com/press-releases/quest-diagnostics-reports-second-quarter-2026-financial-results-raises-revenue-and-eps-guidance-for-full-year-2026",
    "title": "Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 - BioSpace",
    "excerpt": "SECAUCUS, N.J. , July 23, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the second quarter ended June 30, 2026. \"Our robust top- and bottom-line growth in the second quarter demonstrates focused execution of our strategy to connect people and providers to innovative testing and actionable insights that illuminate paths for better health,\" said Jim Davis, Chairman, CEO and President. \"Revenues increased by over 10%, almost all from organic revenue growth across our physician, hospital and consumer channels, and adjusted diluted EPS grew over 19%. With strong growth and sustained demand for our diagnostic insights, we are again raising our full year guidance.\" Recent Highlights: Serving Customers and Delivering Innovations Driving Operational Excellence Three Months Ended June 30, Six Months Ended June 30, 2026 2025 Change 2026 2025 Change (dollars in millions, except per share data) Reported: Net revenues $ 3,043 $ 2,761 10.2 % $ 5,938 $ 5,413 9.7 % Diagnostic Information Services revenues $ 2,978 $ 2,699 10.3 % $ 5,810 $ 5,288 9.9 % Revenue per requisition (2.8) % (2.1) % Requisition volume 13.1 % 12.0 % Organic requisition volume 13.0 % 11.9 % Operating income (a) $ 459 $ 438 4.6 % $ 858 $ 784 9.4 % Operating income as a percentage of net revenues (a) 15.1 % 15.9 %...",
    "summary": "Quest Diagnostics reported net revenues of $3.043 billion for the second quarter ended June 30, 2026, a 10.2% increase year-over-year.",
    "location": "Secaucus, NJ, USA",
    "planning": false,
    "image_url": "https://static.biospace.com/dims4/default/d32393a/2147483647/strip/true/crop/1120x630+40+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F88%2Fa9fddaf440db946b77e1d45d2e26%2Fbiospace-5.png",
    "confidence": 0.95,
    "published_at": "2026-07-23T13:02:38Z",
    "location_data": [
      {
        "city": "Secaucus",
        "state": "New Jersey",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-30",
    "article_sentence": "Net revenues $ 3,043 $ 2,761 10.2 % $ 5,938 $ 5,413 9.7 %",
    "amount_normalized": 3043000000
  }
}

curl https://signals.autobound.ai/v1/signals/29c6687b-2b42-c56d-4cdb-d91e69b9d664 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"questdiagnostics.com","limit":20}'